Have a question?
Open from 8am to 7pm Monday to FridayCall customer services
0345 54 32 600

Prices delayed by at least 15 minutes | Print

Live UK pricing:OffOn

Xtrackers (Ie) Public Limited Company X MSCI GENOMIC HC INNOV UCITS ETF 1C (XGES)

Sell: £24.435|Buy: £24.605|Change: 0.24 (0.98%)

Not yet a customer?

Low cost dealing from £1.50

Choose from our range of SIPP, ISA and Dealing accounts

Open

£24.455

Previous close

£24.2825

Trade high

£24.50

Income frequency

Year low

£19.152

Year high

£25.275

Replication method

Physical Full

Volume

521

Type

ETF

UCITS

Yes

Dividend yield

–

Ongoing charge

0.3

ISIN

IE000KD0BZ68

This share can be held in a Dealing account Stocks and shares ISA Lifetime ISA JISA SIPP

Before investing please read:

Key Investor Information Document (KIID)

Share price

Asset allocation

Top 10 holdings

Holdings 30/09/2025	% of assets
AbbVie Inc	4.87
Agilent Technologies Inc	4.65
Abbott Laboratories	4.47
Natera Inc	4.38
Roche Holding AG	4.34
Vertex Pharmaceuticals Inc	4.32
Lonza Group Ltd	4.18
Danaher Corp	4.06
Bristol-Myers Squibb Co	4.06
Insmed Inc	3.52

Performance 30/09/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

	Total return (%)
Fund	+ 0.98
Category	-
More...

Investment objective

The investment objective of the Fund is to track the performance before fees and expenses of an index which is designed to reflect the performance of the shares of large, medium, and small-capitalisation companies that derive, or are expected to derive, significant revenues from technological innovation in the genomic healthcare sector and which promote, among other characteristics, environmental and social characteristics.

Sustainability Label

This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.

Asset class

ETF

Morningstar rating^TM

Morningstar sustainability rating^TM

Morningstar Medalist Rating^TM

Morningstar analyst document

Morningstar report document

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.